Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension

David Jenkins, David Jenkins

Abstract

Pulmonary endarterectomy (PEA) is the treatment of choice to relieve pulmonary artery obstruction in patients with chronic thromboembolic pulmonary hypertension (CTEPH). It is a complex surgical procedure with a simple principle: removal of obstructive thromboembolic material from the pulmonary arteries in order to reduce pulmonary vascular resistance, relieve pulmonary hypertension (PH) and alleviate right ventricular dysfunction. In the majority of patients there is symptomatic and prognostic benefit. However, not all patients with CTEPH are suitable for treatment with PEA. Operability assessment is not always easy, being largely subjective and based on experience. It is therefore important that all patients are referred to an experienced CTEPH centre for careful evaluation of suitability for surgery. The most common reason for inoperability is distal vasculopathy accounting for a high proportion of the vascular resistance. Surgery requires cardiopulmonary bypass and periods of deep hypothermic circulatory arrest. Complications include reperfusion lung injury and persistent PH. However, with careful patient selection, surgical technique and post-operative management, PEA is a highly effective treatment with mortality rates <5% at experienced centres. Patients who are unsuitable for surgery may be candidates for medical therapy.

Conflict of interest statement

Conflict of interest: Disclosures can be found alongside the online version of this article at err.ersjournals.com

Copyright ©ERS 2015.

Figures

FIGURE 1
FIGURE 1
Example scans for a typical patient with operable chronic thromboembolic pulmonary hypertension. a) Perfusion (Q′) and b) ventilation (V′) lung scans. R: right; L: left; ANT: anterior; POST: posterior; LPO: left posterior oblique; RPO: right posterior oblique. c) Computed tomography pulmonary angiography scan. d) Pulmonary angiogram.
FIGURE 2
FIGURE 2
a) Longitudinal incision in the right pulmonary artery, exposed between the superior vena cava and aorta. b) Developing the endarterectomy dissection plane in the left pulmonary artery. c) Removing the occluded endarterectomy “tails” from the left upper lobe segmental vessels.

References

    1. Galiè N, Hoeper MM, Humbert M, et al. . Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219–1263.
    1. Kim NH, Delcroix M, Jenkins DP, et al. . Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 2013; 62: Suppl. 25, D92–D99.
    1. Hoeper MM, Madani MM, Nakanishi N, et al. . Chronic thromboembolic pulmonary hypertension. Lancet Respir Med 2014; 2: 573–582.
    1. Madani MM, Auger WR, Pretorius V, et al. . Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients. Ann Thorac Surg 2012; 94: 97–103.
    1. Dartevelle P, Fadel E, Mussot S, et al. . Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004; 23: 637–648.
    1. Pepke-Zaba J, Delcroix M, Lang I, et al. . Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 2011; 124: 1973–1981.
    1. Hoey ET, Mirsadraee S, Pepke-Zaba J, et al. . Dual-energy CT angiography for assessment of regional pulmonary perfusion in patients with chronic thromboembolic pulmonary hypertension: initial experience. AJR Am J Roentgenol 2011; 196: 524–532.
    1. Fedullo P, Kerr KM, Kim NH, et al. . Chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2011; 183: 1605–1613.
    1. Taboada D, Pepke-Zaba J, Jenkins DP, et al. . Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease. Eur Respir J 2014; 44: 1635–1645.
    1. Banks DA, Pretorius GV, Kerr KM, et al. . Pulmonary endarterectomy: part I. Pathophysiology, clinical manifestations, and diagnostic evaluation of chronic thromboembolic pulmonary hypertension. Semin Cardiothorac Vasc Anesth 2014; 18: 319–330.
    1. Jensen KW, Kerr KM, Fedullo PF, et al. . Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation 2009; 120: 1248–1254.
    1. Ghofrani HA, D'Armini AM, Grimminger F, et al. . Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 2013; 369: 319–329.
    1. Banks DA, Pretorius GV, Kerr KM, et al. . Pulmonary endarterectomy: part II. Operation, anesthetic management, and postoperative care. Semin Cardiothorac Vasc Anesth 2014; 18: 331–340.
    1. Shenoy V, Anton JM, Collard CD, et al. . Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Anesthesiology 2014; 120: 1255–1261.
    1. Jamieson SW, Kapelanski DP, Sakakibara N, et al. . Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003; 76: 1457–1462.
    1. Ng C, Jenkins DP. Surgical management of chronic thromboembolic pulmonary hypertension. Br J Hosp Med 2013; 74: 31–35.
    1. Kerr KM, Auger WR, Marsh JJ, et al. . Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy. Chest 2012; 141: 27–35.
    1. Mayer E, Jenkins D, Lindner J, et al. . Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 2011; 141: 702–710.
    1. Thistlethwaite PA, Madani MM, Kemp AD, et al. . Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes. Ann Thorac Surg 2006; 82: 2139–2145.
    1. Gan HL, Zhang JQ, Sun JC, et al. . Preoperative transcatheter occlusion of bronchopulmonary collateral artery reduces reperfusion pulmonary edema and improves early hemodynamic function after pulmonary thromboendarterectomy. J Thorac Cardiovasc Surg 2014; 148: 3014–3019.
    1. Jenkins DP, Madani M, Mayer E, et al. . Surgical treatment of chronic thromboembolic pulmonary hypertension. Eur Respir J 2013; 41: 735–742.
    1. Thomson B, Tsui SS, Dunning J, et al. . Pulmonary endarterectomy is possible and effective without the use of complete circulatory arrest – the UK experience in over 150 patients. Eur J Cardiothorac Surg 2008; 33: 157–163.
    1. Vuylsteke A, Sharples L, Charman G, et al. . Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial. Lancet 2011; 378: 1379–1387.
    1. Morsolini M, Nicolardi S, Milanesi E, et al. . Evolving surgical techniques for pulmonary endarterectomy according to the changing features of chronic thromboembolic pulmonary hypertension patients during 17-year single-center experience. J Thorac Cardiovasc Surg 2012; 144: 100–107.
    1. Baglin TP, Brush J, Streiff M. Guidelines on use of vena cava filters. Br J Haematol 2006; 134: 590–595.
    1. Jamieson SW, Kapelanski DP. Pulmonary endarterectomy. Curr Probl Surg 2000; 37: 165–252.
    1. Lang IM, Madani M. Update on chronic thromboembolic pulmonary hypertension. Circulation 2014; 130: 508–518.
    1. D'Armini AM, Morsolini M, Mattiucci G, et al. . Pulmonary endarterectomy for distal chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 2014; 148: 1005–1011.
    1. Freed DH, Thomson BM, Berman M, et al. . Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg 2011; 141: 383–387.
    1. Corsico AG, D'Armini AM, Cerveri I, et al. . Long-term outcome after pulmonary endarterectomy. Am J Respir Crit Care Med 2008; 178: 419–424.
    1. Riedel M, Stanek V, Widimsky J, et al. . Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982; 81: 151–158.
    1. Kunieda T, Nakanishi N, Satoh T, et al. . Prognoses of primary pulmonary hypertension and chronic major vessel thromboembolic pulmonary hypertension determined from cumulative survival curves. Intern Med 1999; 38: 543–546.
    1. Condliffe R, Kiely DG, Gibbs JS, et al. . Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2008; 177: 1122–1127.
    1. Freed DH, Thomson BM, Tsui SS, et al. . Functional and haemodynamic outcome 1 year after pulmonary thromboendarterectomy. Eur J Cardiothorac Surg 2008; 34: 525–529.
    1. Ishida K, Masuda M, Tanabe N, et al. . Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 2012; 144: 321–326.
    1. Bonderman D, Skoro-Sajer N, Jakowitsch J, et al. . Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation 2007; 115: 2153–2158.
    1. Kim NH, Fesler P, Channick RN, et al. . Preoperative partitioning of pulmonary vascular resistance correlates with early outcome after thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Circulation 2004; 109: 18–22.
    1. Berman M, Tsui S, Vuylsteke A, et al. . Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy. Ann Thorac Surg 2008; 86: 1261–1267.
    1. Kramm T, Eberle B, Guth S, et al. . Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J Cardiothorac Surg 2005; 28: 882–888.
    1. Hoeper MM. Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension. Eur Respir Rev 2015; 24: 272–282.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir